Modelling the likely effect of the increase of the upper age limit from 70 to 73 for breast screening in the UK National Programme

Statistical Methods in Medical Research

Volumn 19, Issue 5, 2010, Pages 547-555

  Duffy, S W ^a   Sasieni, P ^a   Olsen, A H ^a   Cafferty, F H ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; COST EFFECTIVENESS ANALYSIS; FEMALE; GROUPS BY AGE; HEALTH PROGRAM; HUMAN; STOCHASTIC MODEL; UNITED KINGDOM;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; MARKOV CHAINS; MASS SCREENING; MODELS, STATISTICAL; STOCHASTIC PROCESSES;

EID: 77957784804     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280209358140     Document Type: Article

References (9)

1. Chen HH, Duffy SW, Tabar L., Day NE Markov chain models for progression of breast cancer, part 1: tumour attributes and the preclinical screen-detectable phase. Journal of Epidemiology and Biostatistics 1997 ; 2: 9-23.
2. Yen MF, Tabar L., Vitak B., Smith RA, Chen HH, Duffy SW Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. European Journal of Cancer 2003 ; 39: 1746-1754
3. Day NE, Walter SD Simplified models of screening for chronic disease: estimation procedures from mass screening programmes. Biometrics 1984 ; 40: 1-13.
4. Office for National Statistics. Cancer statistics: registrations 2003. Her Majesty's Stationery Office, London ; 2005.
5. Office for National Statistics. Mortality statistics: cause 2004. Her Majesty's Stationery Office, London ; 2005.
6. Tabar L., Vitak B., Chen HH, Duffy SW, Smith RA The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long term follow-up. Radiologic Clinics of North America 2000 ; 38: 625-651.
7. Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future. NHS Cancer Screening Programmes, Sheffield ; 2006.
8. Pearson SD, Rawlins MD Quality, innovation and value for money: NICE and the British Health Service. Journal of the American Medical Association 2005 ; 294: 2618-2622.
9. Bennett RL, Blanks RG, Moss SM Evaluation of extension of breast screening to women aged 65-70 in England using screening performance measures. British Journal of Cancer 2009 ; 100: 1043-1047.